MedTrace Logo

Assessment of Three Basic Progressive Lens Designs

NCT05252871 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-08-15

Study results available
· View outcomes & findings →

Summary

This clinical trial investigates the differences between three different progressive addition lens designs. It is a non-invasive double-masked randomized clinical investigation. For this study, 80 participants will be recruited.

Conditions

Interventions

DEVICE

Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating

Subjects will be wearing three different PAL designs with different geometries of the optical progression.

Sponsors & Collaborators

  • Hoya Vision Care

    collaborator INDUSTRY

  • Western University of Health Sciences

    lead OTHER

Principal Investigators

  • Frank Spors, Ph.D. · Western University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-09
Primary Completion
2022-06-06
Completion
2022-06-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05252871 on ClinicalTrials.gov